Data Presented At The 5th Joint Triennial Congress Of ECTRIMS And ACTRIMS ... (press release)
... marketed products, TYSABRI ® (natalizumab), AVONEX ® (interferon beta-1a) and FAMPYRA ® (prolonged-release fampridine), as well as two late-stage investigational compounds, oral BG-12 (dimethyl fumarate) and daclizumab high-yield process (DAC HYP). ...
Data Presented at the 5th Joint Triennial Congress of ECTRIMS and ACTRIMS ...MarketWatch (press release)

all 12 news articles »